Format

Send to

Choose Destination
Ann Gastroenterol. 2012;25(2):96-99.

Current management of functional dyspepsia: impact of Rome III subdivision.

Author information

1
Gastroenterology Unit, 2 Surgical Department, Aretaieion Hospital, Athens Medical School, Athens, Greece (Georgios P. Karamanolis).
2
Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, University of Leuven, Leuven, Belgium (Jan Tack).

Abstract

Functional dyspepsia (FD) is a highly prevalent disease characterized by symptoms originating from the gastroduodenal region in the absence of underlying organic disease. The Rome III consensus made a distinction between meal-induced and meal-unrelated symptoms and proposed subdivision of FD into postprandial distress syndrome and epigastric pain syndrome. The applicability of this subdivision and the impact on management are areas of active research. So far, empirical approaches are still employed for the treatment of FD, although various therapeutic modalities for FD have been explored; acid-suppressive, prokinetic, and fundic relaxant drugs, antidepressants and psychological therapies. FD remains a challenge and presents unmet clinical needs.

KEYWORDS:

Rome III; functional dyspepsia; treatment

PMID:
24714074
PMCID:
PMC3959396

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center